Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-Exposure Prophylaxis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT01855867
What this trial is testing

HIV Non-Occupational Post-Exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus
Kenneth H. Mayer, MD 100
Not applicableUnknownNCT03775083
What this trial is testing

What Happens in Vegas: PEP to PrEP Opportunities

Who this might be right for
Exposure to Human Immunodeficiency Virus (Event)
Huntridge Family Clinic 75
Post-approval studies (Phase 4)Study completedNCT04860505
What this trial is testing

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

Who this might be right for
Sexually Transmitted Diseases
Emory University 20
Post-approval studies (Phase 4)UnknownNCT01173302
What this trial is testing

Persistence of Rabies Antibody 1-5 Years After the Post-exposure Prophylaxis With Vero Cell Antirabies Vaccine and Antibody Response to a Single Booster Dose

Who this might be right for
Rabies
Peking University People's Hospital 160
Not applicableTemporarily pausedNCT02915497
What this trial is testing

Early Prevention of PTSD in Patients Within One Week of Acute Physical Trauma

Who this might be right for
Post Traumatic Stress Disorder
Sunnybrook Health Sciences Centre 20
Large-scale testing (Phase 3)Study completedNCT04594551
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 201
Large-scale testing (Phase 3)Study completedNCT04359680
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Nitazoxanide (NTZ) for Pre- and Post Exposure Prophylaxis of COVID-19 and Other Viral Respiratory Illnesses (VRI) in Healthcare Workers and Others at Increased Risk of SARS-CoV-2 Infection

Who this might be right for
COVID-19Viral Respiratory Illnesses
Romark Laboratories L.C. 1,407
Post-approval studies (Phase 4)Study completedNCT01576731
What this trial is testing

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Who this might be right for
HIV Infection
Hospital Clinic of Barcelona 240
Not applicableStudy completedNCT00139139
What this trial is testing

Compare the Efficacy of Hepatitis A Vaccine and Immune Globulin When Given After Exposure to Hepatitis A

Who this might be right for
Hepatitis A
Centers for Disease Control and Prevention 1,500
Not applicableUnknownNCT04438837
What this trial is testing

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Who this might be right for
Coronavirus Disease 2019 (COVID-19)Post-Exposure Prophylaxis
Rambam Health Care Campus 582
Large-scale testing (Phase 3)Study completedNCT01107275
What this trial is testing

Early Rabies Vaccine Immunization in Primary School Children

Who this might be right for
Rabies Prevention
Provincial Public Health Office, Phetchabun 703
Testing effectiveness (Phase 2)Study completedNCT03961555
What this trial is testing

Comparison of SYN023 to Human Rabies Immune Globulin in Post Exposure Prophylaxis of Rabies

Who this might be right for
Rabies
Synermore Biologics Co., Ltd. 448
Not applicableStudy completedNCT05589233
What this trial is testing

COVID-19 Vaccination AZV 2021-2023

Who this might be right for
COVID-19VaccinationImmunity+1 more
University Hospital Hradec Kralove 3,000
Large-scale testing (Phase 3)Study completedNCT04644484
What this trial is testing

A Phase III Clinical Study to Evaluate SYN023's Efficacy and Safety

Who this might be right for
RabiesCommunicable DiseaseVirus Diseases+3 more
Synermore Biologics (Suzhou) Co., Ltd. 1,000
Early research (Phase 1)Study completedNCT01353040
What this trial is testing

Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus

Who this might be right for
Marburg Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Large-scale testing (Phase 3)Not Yet RecruitingNCT07658976
What this trial is testing

Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy

Who this might be right for
HIV InfectionSexually Transmitted Infection
HIV Prevention Trials Network 400
Post-approval studies (Phase 4)Active Not RecruitingNCT06188442
What this trial is testing

Superiority of On-demand PrEP Versus PEP on Using Doxycycline for Preventing STI in MSM

Who this might be right for
Sexually Transmitted Diseases, BacterialSyphilisGonorrhea+1 more
Chinese University of Hong Kong 300
Early research (Phase 1)Active Not RecruitingNCT05890963
What this trial is testing

10E8.4/iMab Bispecific Antibody and VRC07-523LS Monoclonal Antibody in HIV-infected Adults

Who this might be right for
HIV-1-infection
David Ho 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT06841614
What this trial is testing

EBOla Post-Exposure Prophylaxis

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 160
Next Page